Candida in Lung Specimens from Non-Neutropenic ICU Patients: Infection or Colonization ?

  • E. Azoulay
  • B. Schlemmer
Conference paper


Candida is an opportunistic yeast normally found in the oral cavity and gastrointestinal tract. Its ability to multiply and to invade the bloodstream and deep tissues is increasing. This has produced new clinical patterns of systemic disease whose expression is dependent on the immune status of the host. Thus, presence of Candida is intimately linked to the effects of chemotherapy and radiation therapy for cancer, hematological malignancies, human immunodeficiency virus (HIV) infection, malnutrition, corticosteroid therapy, and broad-spectrum antibiotics.


Intensive Care Unit Patient Invasive Candidiasis Candida Colonization Lung Specimen Systemic Candidiasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Ascioglu S, Rex JH, de Pauw B, et al (2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 34: 7–14PubMedCrossRefGoogle Scholar
  2. 2.
    Vincent JL, Bihari DJ, Suter PM, et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274: 639–644Google Scholar
  3. 3.
    Stephan F, Yang K, Tankovic J, et al (2002) Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients. Crit Care Med 30: 315322Google Scholar
  4. 4.
    Nakos G, Malamou-Mitsi VD, Lachana A, et al (2002) Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma. Crit Care Med 30: 1488–1494PubMedCrossRefGoogle Scholar
  5. 5.
    Kox WJ, Volk T, Kox SN, Volk HD (2000) Immunomodulatory therapies in sepsis. Intensive Care Med 26: S124–128PubMedCrossRefGoogle Scholar
  6. 6.
    Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20: 1526–1530PubMedCrossRefGoogle Scholar
  7. 7.
    Eggimann P, Francioli P, Bille J, et al (1999) Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27: 1066–1072PubMedCrossRefGoogle Scholar
  8. 8.
    Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220: 751–758PubMedCrossRefGoogle Scholar
  9. 9.
    Vincent JL, Anaissie E, Bruining H, et al (1998) Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med 24: 206–216PubMedCrossRefGoogle Scholar
  10. 10.
    Fernandez-Sola J, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A (1995) High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 155: 1649–1654PubMedCrossRefGoogle Scholar
  11. 11.
    Wheat LJ (1980) Infection and diabetes mellitus. Diabetes Care 3: 187–197PubMedCrossRefGoogle Scholar
  12. 12.
    Chen KY, Ko SC, Hsueh PR, Luh KT, Yang PC (2001) Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest 120: 177–184PubMedCrossRefGoogle Scholar
  13. 13.
    von Eiff M, Roos N, Fegeler W, et al (1994) Pulmonary fungal infections in immunocompromised patients: incidence and risk factors. Mycoses 37: 329–335Google Scholar
  14. 14.
    von Eiff M, Zuhlsdorf M, Roos N, Hesse M, Schulten R, van de Loo J (1995) Pulmonary fungal infections in patients with hematological malignancies–diagnostic approaches. Ann Hematol 70: 135–141CrossRefGoogle Scholar
  15. 15.
    Bodey GP (1984) Candidiasis in cancer patients. Am J Med 77: 13–19PubMedGoogle Scholar
  16. 16.
    Masur H, Rosen PP, Armstrong D (1977) Pulmonary disease caused by Candida species. Am J Med 63: 914–925PubMedCrossRefGoogle Scholar
  17. 17.
    Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 149: 2349–2353Google Scholar
  18. 18.
    Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital-acquired candide-mia. The attributable mortality and excess length of stay. Arch Intern Med 148: 2642–2645Google Scholar
  19. 19.
    Petri MG, Konig J, Moecke HP, et al (1997) Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med 23: 317–325Google Scholar
  20. 20.
    Eubanks PJ, de Virgilio C, Klein S, Bongard F (1993) Candida sepsis in surgical patients. Am J Surg 166: 617–619PubMedCrossRefGoogle Scholar
  21. 21.
    Eggimann P, Pittet D (2001) [Candidiasis among non-neutropenic patients: from colonization to infection]. Ann Fr Anesth Reanim 20: 382–388Google Scholar
  22. 22.
    Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP (2002) Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 35: 627–630PubMedCrossRefGoogle Scholar
  23. 23.
    Leleu G, Aegerter P, Guidet B (2002) Systemic candidiasis in intensive care units: A multicenter, matched-cohort study. J Crit Care 17: 168–175Google Scholar
  24. 24.
    Blot S, Vandewoude K, Hoste E, Poelaert J, Colardyn F (2001) Outcome in critically ill patients with candidal fungaemia: Candida albicans vs Candida glabrata. J Hosp Infect 47: 308–313Google Scholar
  25. 25.
    Rangel-Frausto MS, Wiblin T, Blumberg HM, et al (1999) National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29: 253–258PubMedCrossRefGoogle Scholar
  26. 26.
    Goodman JL, Winston DJ, Greenfield RA, et al (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326: 845–851PubMedCrossRefGoogle Scholar
  27. 27.
    MacMillan ML, Goodman JL, DeFor TE, Weisdorf DJ (2002) Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy. Am J Med 112: 369379Google Scholar
  28. 28.
    Winston DJ, Chandrasekar PH, Lazarus HM, et al (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 118: 495–503Google Scholar
  29. 29.
    Pelz RK, Hendrix CW, Swoboda SM, et al (2001) Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg 233: 542–548PubMedCrossRefGoogle Scholar
  30. 30.
    Garbino J, Lew D, Romand J-A, Hugonnet S, Auckenthaler R, Pittet D (2002) Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients. A randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med 28: 1708–1717Google Scholar
  31. 31.
    Calandra T, Marchetti O (2003) Antifungal prophylaxis for intensive care unit patients: let’s fine tune it. Intensive Care Med (in press)Google Scholar
  32. 32.
    Rex JH, Sobel JD (2001) Prophylactic antifungal therapy in the intensive care unit. Clin Infect Dis 32: 1191–1200PubMedCrossRefGoogle Scholar
  33. 33.
    Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP (1993) Primary Candida pneumonia. Experience at a large cancer center and review of the literature. Medicine (Baltimore) 72: 137–142Google Scholar
  34. 34.
    Rose HD, Sheth NK (1978) Pulmonary candidiasis. A clinical and pathological correlation. Arch Intern Med 138: 964–965Google Scholar
  35. 35.
    Azoulay E, Limal N, Mayaud C, Schlemmer B (2001) Bronchial specimens positive to candida: infection or colonization. Réanimation 10: 323–328CrossRefGoogle Scholar
  36. 36.
    Azoulay E, Mayaud C (1999) [Candida pneumopathy: fact or fiction?]. Rev Pneumol Clin 55: 349–351Google Scholar
  37. 37.
    el-Ebiary M, Torres A, Fabregas N, et al (1997) Significance of the isolation of Candida species from respiratory samples in critically ill, non-neutropenic patients. An immediate postmortem histologic study. Am J Respir Crit Care Med 156: 583–590Google Scholar
  38. 38.
    Rello J, Esandi ME, Diaz E, Mariscal D, Gallego M, Valles J (1998) The role of Candida sp isolated from bronchoscopic samples in nonneutropenic patients. Chest 114: 146–149PubMedCrossRefGoogle Scholar
  39. 39.
    Kaposzta R, Tree P, Marodi L, Gordon S (1998) Characteristics of invasive candidiasis in gamma interferon-and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 66: 1708–1717PubMedGoogle Scholar
  40. 40.
    Aratani Y, Kura F, Watanabe H, et al (2000) Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase. J Infect Dis 182: 1276–1279PubMedCrossRefGoogle Scholar
  41. 41.
    Aratani Y, Koyama H, Nyui S, Suzuki K, Kura F, Maeda N (1999) Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase. Infect Immun 67: 1828–1836PubMedGoogle Scholar
  42. 42.
    Kubota Y, Iwasaki Y, Harada H, et al (2001) Role of alveolar macrophages in Candida-induced acute lung injury. Clin Diagn Lab Immunol 8: 1258–1262PubMedGoogle Scholar
  43. 43.
    Fulurija A, Ashman RB, Papadimitriou JM (1996) Early inflammatory responses to Candida albicans infection in inbred and complement-deficient mice. FEMS Immunol Med Microbiol 14: 83–94PubMedCrossRefGoogle Scholar
  44. 44.
    Fulurija A, Ashman RB, Papadimitriou JM (1996) Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 142: 3487–3496PubMedCrossRefGoogle Scholar
  45. 45.
    Marodi L, Forehand JR, Johnston RB Jr (1991) Mechanisms of host defense against Candida species. II. Biochemical basis for the killing of Candida by mononuclear phagocytes. J Immunol 146: 2790–2794Google Scholar
  46. 46.
    Marodi L, Korchak HM, Johnston RB Jr (1991) Mechanisms of host defense against Candida species. I. Phagocytosis by monocytes and monocyte-derived macrophages. J Immunol 146: 2783–2789Google Scholar
  47. 47.
    Marodi L (1997) Local and systemic host defense mechanisms against Candida: immunopathology of candidal infections. Pediatr Infect Dis J 16: 795–801PubMedCrossRefGoogle Scholar
  48. 48.
    Blasi E, Pitzurra L, Puliti M, et al (1994) Different events involved in the induction of macrophage tumor necrosis factor by Candida albicans and lipopolysaccharide. Cell Immunol 157: 501–509PubMedCrossRefGoogle Scholar
  49. 49.
    Newman SL, Holly A (2001) Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells. Infect Immun 69: 6813–6822PubMedCrossRefGoogle Scholar
  50. 50.
    Marodi L, Tournay C, Kaposzta R, Johnston RB Jr, Moguilevsky N (1998) Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect Immun 66: 2750–2754PubMedGoogle Scholar
  51. 51.
    Marodi L, Johnston RB Jr (1993) Enhancement of macrophage candidacidal activity by interferon-gamma. Immunodeficiency 4: 181–185PubMedGoogle Scholar
  52. 52.
    Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB Jr (1993) Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 91: 2596–2601Google Scholar
  53. 53.
    British Society for Antimicrobial Chemotherapy Working Party (1994) Management of deep Candida infection in surgical and intensive care unit patients. Intensive Care Med 20: 522–528CrossRefGoogle Scholar
  54. 54.
    Rex JH, Walsh TJ, Sobel JD, et al (2000) Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis 30: 662–678Google Scholar
  55. 55.
    Cakar N, Akinci 0, Tugrul S, et al (2002) Recruitment maneuver: does it promote bacterial translocation? Crit Care Med 30: 2103–2106PubMedCrossRefGoogle Scholar
  56. 56.
    Murphy DB, Cregg N, Tremblay L, et al (2000) Adverse ventilatory strategy causes pulmonary-to-systemic translocation of endotoxin. Am J Respir Crit Care Med 162: 27–33PubMedCrossRefGoogle Scholar
  57. 57.
    Nahum A, Hoyt J, Schmitz L, Moody J, Shapiro R, Marini JJ (1997) Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs. Crit Care Med 25: 1733–1743PubMedCrossRefGoogle Scholar
  58. 58.
    Torres A, El-Ebiary M, Soler N, Monton C, Fabregas N, Hernandez C (1996) Stomach as a source of colonization of the respiratory tract during mechanical ventilation: association with ventilator-associated pneumonia. Eur Respir J 9: 1729–1735PubMedCrossRefGoogle Scholar
  59. 59.
    Rogers T, Balish E (1976) Experimental Candida albicans infection in conventional mice and germfree rats. Infect Immun 14: 33–38PubMedGoogle Scholar
  60. 60.
    Katz S, Merkel GJ, Folkening WJ, Rosenthal RS, Grosfeld JL (1991) Impaired clearance and organ localization of Candida albicans in obstructive jaundice. J Pediatr Surg 26: 904–906PubMedCrossRefGoogle Scholar
  61. 61.
    Lechner AJ, Tredway TL, Brink DS, Klein CA, Matuschak GM (1992) Differential systemic and intrapulmonary TNF-alpha production in Candida sepsis during immunosuppression. Am J Physiol 263: L526–535PubMedGoogle Scholar
  62. 62.
    Katz S, Merkel GJ, Folkening WJ, Rosenthal RS, Grosfeld JL (1993) Blood clearance and organ localization of Candida albicans and E coli following dual infection in rats. J Pediatr Surg 28: 329–332Google Scholar
  63. 63.
    Lechner AJ, Lamprech KE, Potthoff LH, Tredway TL, Matuschak GM (1994) Recombinant GM-CSF reduces lung injury and mortality during neutropenic Candida sepsis. Am J Physiol 266: L561–568PubMedGoogle Scholar
  64. 64.
    Samaranayake LP, Tobgi RS, MacFarlane TW (1994) Anti-candida activity of murine bronchoalveolar lavage fluid. J Med Microbiol 40: 350–357PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • E. Azoulay
  • B. Schlemmer

There are no affiliations available

Personalised recommendations